A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization

Cardiovascular Research

Volumn 59, Issue 1, 2003, Pages 27-36

  Bezzina, Connie R ^a   Verkerk, Arie O ^a   Busjahn, Andreas ^b   Jeron, Andreas ^c   Erdmann, Jeanette ^c   Koopmann, Tamara T ^a   Bhuiyan, Zahurul A ^a   Wilders, Ronald ^a   Mannens, Marcel M A M ^a   Tan, Hanno L ^a   Luft, Friedrich C ^b   Schunkert, Heribert ^c   Wilde, Arthur A M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Arrhythmias; ECG; Epidemiology; Ion channels; K channel

Indexed keywords

AMINO ACID; ION; ION CHANNEL; PROTEIN; PROTEIN KCNH2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ANALYTICAL PARAMETERS; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ELECTRIC CURRENT; ETHNOLOGY; FEMALE; GENE ACTIVATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART ARRHYTHMIA; HEART DISEASE; HEART REPOLARIZATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; QT INTERVAL; SEX DIFFERENCE; STRATIFICATION; VOLTAGE CLAMP;

ACTION POTENTIALS; ADULT; AGED; BASE SEQUENCE; CATION TRANSPORT PROTEINS; COMPUTER SIMULATION; DNA-BINDING PROTEINS; ELECTROCARDIOGRAPHY; ETHER-A-GO-GO POTASSIUM CHANNELS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENOTYPE; HEART; HOMOZYGOTE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SEQUENCE ANALYSIS, DNA; SEX FACTORS; TRANS-ACTIVATORS;

EID: 0038433342     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00342-0     Document Type: Article

References (38)

1. Puddu P.E., Bourassa M.G. Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol. 19:1986;203-212.
2. Schwartz P.J., Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 57:1978;1074-1077.
3. Ahnve S. QT interval prolongation in acute myocardial infarction. Eur Heart J. 6:(Suppl. D):1985;85-95.
4. Schouten E.G., Dekker J.M., Meppelink P., et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 84:1991;1516-1523.
5. Okin P.M., Devereux R.B., Howard B.V., et al. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation. 101:2000;61-66.
6. Brendorp B., Elming H., Jun L., et al. QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation. 103:2001;1422-1427.
7. Roden D.M. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res. 50:2001;224-231.
8. Makkar R.R., Fromm B.S., Steinman R.T., et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. J Am Med Assoc. 270:1993;2590-2597.
9. Hohnloser S.H., Singh B.N. Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol. 6:1995;920-936.
10. Priori S.G., Barhanin J., Hauer R.N., et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management. Parts I and II. Circulation. 99:1999;518-528.
11. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA. 93:1996;2208-2212.
12. Hanson B., Tuna N., Bouchard T., et al. Genetic factors in the electrocardiogram and heart rate of twins reared apart and together. Am J Cardiol. 63:1989;606-609.
13. Busjahn A., Knoblauch H., Faulhaber H.D., et al. QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation. 99:1999;3161-3164.
14. Priori S.G., Napolitano C., Schwartz P.J. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 99:1999;529-533.
15. Priori S.G., Napolitano C., Gasparini M., et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome. A prospective evaluation of 52 families. Circulation. 102:2000;2509-2515.
16. Kyndt F., Probst V., Potet F., et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation. 104:2001;3081-3086.
17. Brugada R., Roberts R. Brugada syndrome: why are there multiple answers to a simple question? Circulation. 104:2001;3017-3019.
18. Yang P., Kanki H., Drolet B., et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 105:2002;1943-1948.
19. Muscholl M.W., Hense H.W., Bröckel U., et al. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. Br Med J. 317:1998;565-570.
20. Hoppe U.C., Marbán E., Johns D.C. Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1. Proc Natl Acad Sci USA. 98:2001;5335-5340.
21. Johns D.C., Nuss H.B., Marbán E. Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs. J Biol Chem. 272:1997;31598-31603.
22. Sanguinetti M.C., Jiang C., Curran M.E., Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 81:1995;299-307.
23. Smith P.L., Baukrowitz T., Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature. 379:1996;833-836.
24. Snyders D.J., Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol. 49:1996;949-955.
25. Zhou Z., Gong Q., Ye B., et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J. 74:1998;230-241.
26. Priebe L., Beuckelmann D.J. Simulation study of cellular electric properties in heart failure. Circ Res. 82:1998;1206-1223.
27. Warmke J.W., Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA. 91:1994;3438-3442.
28. + channel in mouse and human hearts. Circ Res. 81:1997;719-726.
29. Bauer C.K., Engeland B., Wulfsen I., et al. RERG is a molecular correlate of the inward-rectifying K current in clonal rat pituitary cells. Receptors Channels. 6:1998;19-29.
30. Merri M., Benhorin J., Alberti M., et al. Electrocardiographic quantitation of ventricular repolarization. Circulation. 80:1989;1301-1308.
31. Lehmann M.H., Timothy K.W., Frankovich D., et al. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol. 29:1997;93-99.
32. Rautaharju P.M., Zhou S.H., Wong S., et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 8:1992;690-695.
33. Zareba W., Moss A.J., le Cessie S., et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol. 26:1995;1685-1691.
34. Lehmann M.H., Hardy S., Archibald D., et al. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation. 94:1996;2535-2541.
35. Laitinen P., Fodstad H., Piippo K., et al. Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Mutation in brief #334. Online Hum Mutat. 15:2000;580-581.
36. Pietilä E., Fodstad H., Niskasaari E., et al. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol. 40:2002;511-514.
37. Roden D.M., Balser J.R. A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology. Cardiovasc Res. 44:1999;242-246.
38. Splawski I., Timothy K.W., Tateyama M., et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 297:2002;1333-1336.